Ryutaro Hazuki, a former infielder for the Hiroshima Toyo Carp, was found guilty Friday of violating the Pharmaceuticals and Medical Devices Act [1].
The case highlights the rising concern over the use of designated illegal substances among professional athletes and the public in Japan. The drug in question, etomidate, is commonly referred to as "zombie tobacco" due to the dissociative effects it produces [2].
The Hiroshima District Court sentenced the 26-year-old Hazuki [5] to one year in prison, though the sentence was suspended for three years [1], [2]. The court heard that Hazuki used the substance at his home around Dec. 16, 2025 [6].
Public interest in the proceedings was high. More than 500 people lined up for the trial [1], while only 46 seats were available in the gallery [1]. During the proceedings, Hazuki said, "It is correct" [1], regarding the charges brought against him.
In a separate statement, Hazuki said, "surrounding Carp players were also smoking" [3]. This comment suggests a broader issue of substance use within the team environment, though no other specific players were named in the court's findings.
The Pharmaceuticals and Medical Devices Act regulates the handling and use of specific chemicals to prevent addiction and public health crises. Etomidate, while used in clinical settings as an anesthetic, is strictly prohibited for recreational use as a designated substance in Japan [2].
“"It is correct"”
The sentencing of a former professional athlete for using etomidate underscores the Japanese judiciary's strict stance on 'designated substances.' By granting a suspended sentence, the court acknowledged the defendant's circumstances while still establishing a criminal record. Hazuki's claim that other players used the drug may prompt further scrutiny of health and compliance protocols within professional baseball organizations.
